161 related articles for article (PubMed ID: 3524434)
1. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
Datta P; Sen D
Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
[TBL] [Abstract][Full Text] [Related]
6. Epidemic Shiga bacillus dysentery in Central Africa.
Ebright JR; Moore EC; Sanborn WR; Schaberg D; Kyle J; Ishida K
Am J Trop Med Hyg; 1984 Nov; 33(6):1192-7. PubMed ID: 6391226
[TBL] [Abstract][Full Text] [Related]
7. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
Engels D; Madaras T; Nyandwi S; Murray J
Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.
Bogaerts J; Verhaegen J; Munyabikali JP; Mukantabana B; Lemmens P; Vandeven J; Vandepitte J
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):165-71. PubMed ID: 9327243
[TBL] [Abstract][Full Text] [Related]
9. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa.
Frost JA; Willshaw GA; Barclay EA; Rowe B; Lemmens P; Vandepitte J
J Hyg (Lond); 1985 Apr; 94(2):163-72. PubMed ID: 3886782
[TBL] [Abstract][Full Text] [Related]
10. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
Paquet C; Leborgne P; Sasse A; Varaine F
Sante; 1995; 5(3):181-4. PubMed ID: 7640901
[TBL] [Abstract][Full Text] [Related]
11. Response to antimicrobial therapy for shigellosis in Thailand.
Lolekha S; Vibulbandhitkit S; Poonyarit P
Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
[TBL] [Abstract][Full Text] [Related]
12. Multiresistant Shigella infections in Bangladesh.
Bennish M; Eusof A; Kay B; Wierzba T
Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
[No Abstract] [Full Text] [Related]
13. Nalidixic-acid-resistant Shigella dysenteriae I.
Panhotra BR; Desai B; Sharma PL
Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
[No Abstract] [Full Text] [Related]
14. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for death in hospitalized dysentery patients in Rwanda.
Legros D; Paquet C; Dorlencourt F; Saoult E
Trop Med Int Health; 1999 Jun; 4(6):428-32. PubMed ID: 10444318
[TBL] [Abstract][Full Text] [Related]
16. Nalidixic acid in Shigella dysenteriae outbreaks.
Malengreau M
Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
[No Abstract] [Full Text] [Related]
17. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid.
Bennish ML; Salam MA; Hossain MA; Myaux J; Khan EH; Chakraborty J; Henry F; Ronsmans C
Clin Infect Dis; 1992 May; 14(5):1055-60. PubMed ID: 1600006
[TBL] [Abstract][Full Text] [Related]
18. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention.
Ries AA; Wells JG; Olivola D; Ntakibirora M; Nyandwi S; Ntibakivayo M; Ivey CB; Greene KD; Tenover FC; Wahlquist SP
J Infect Dis; 1994 May; 169(5):1035-41. PubMed ID: 8169388
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
Munshi MH; Sack DA; Haider K; Ahmed ZU; Rahaman MM; Morshed MG
Lancet; 1987 Aug; 2(8556):419-21. PubMed ID: 2887725
[TBL] [Abstract][Full Text] [Related]
20. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
Jahan Y; Hossain A
J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
